MedPath

Fumerix-250

Brand Name: Fumerix-250

Generic Name: Cefuroxime (as sodium)

Active
Registration Number

DR-XY35284

Dosage Form

Powder For Injection (Im/Iv)

Issuance Date

February 5, 2024

Expiry Date

January 9, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength250 mg
PackagingIndividually Boxed Type III Clear and Colorless Glass Vial with Green Flip-off Seal + Type I Clear and Colorless Glass Ampoule x 10mL (Sterile Water for Injection as Diluent) (Box of 1's and 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Cephalosporin)
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cefuroxime (as sodium)Active
Monograph: cefuroxime (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform